The AHA today urged the Occupational Safety and Health Administration not to finalize its emergency temporary standard for occupational exposure to COVID-19, saying it continues to oppose establishing new regulations that are not fully aligned with the Centers for Disease Control and Prevention’s evolving evidence-based guidance.

“With the constantly evolving, science-based CDC guidance and recommendations, CMS’ vaccination requirement and existing OSHA general standards, we strongly believe that an inconsistent and overly strict OSHA COVID-19 health care standard is not necessary, would cause confusion and will ultimately lower hospital employees’ morale and worsen unprecedented personnel shortages in hospitals,” AHA wrote. “It is essential to a well-functioning health care system that only one set of science-based standards be applied to health care providers, and that these standards be aligned across federal agencies.”

OSHA last month requested additional comments on certain topics in its interim final rule, and announced an informal public hearing beginning April 27 to gather additional information from stakeholders as it develops a final rule.

Related News Articles

Perspective
As Congress convenes for its post-election lame-duck session, we are turning up the pressure to secure additional support for hospitals and the patients and…
Headline
The Food and Drug Administration does not currently authorize the monoclonal antibody bamlanivimab for emergency use to treat mild-to-moderate COVID-19 in the…
Headline
The Centers for Disease Control and Prevention yesterday awarded public health departments $3.14 billion over five years to recruit, retain and train public…
Headline
U.S. hospitals and health systems in October experienced their 10th consecutive month of negative operating margins, Kaufman Hall reported today. Median…
Headline
A new memorandum from the Centers for Medicare & Medicaid Services is reinforcing the agency’s role in enforcing regulatory expectations that patients and…
Headline
In a study of symptomatic adults tested for SARS-CoV-2 at U.S. pharmacies since Sept. 14, bivalent COVID-19 vaccine boosters provided additional protection…